A critical re-analysis of cases of post-transplantation recurrence in genetic nephrotic syndrome
Open Access
- 24 May 2021
- journal article
- research article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 36 (11) , 3757-3769
Abstract
Background: Genetic defects in podocyte proteins account for up to 30% of steroid-resistant nephrotic syndrome (SRNS) in the paediatric population. Most children with genetic SRNS are resistant to immunosuppression and at high risk of progression to stage 5 chronic kidney disease. Kidney transplantation is often the treatment of choice. The possibility of post-transplantation disease recurrence in genetic SRNS remains controversial, and poses fundamental questions about disease biology. Methods: We critically evaluated the published cases of post-transplantation recurrence in genetic patients, particularly testing ‘mutations’ against the most recent population variant databases, in order to clarify the diagnoses, and compare the clinical courses and responses to therapy. Results: Biallelic pathogenic variants in NPHS1 leading to a complete absence of nephrin were the most commonly reported and best understood instance of nephrotic syndrome occurring post-transplantation. This is an immune-mediated process driven by antibody production against the novel nephrin protein in the allograft. We also identified a number of plausible reported cases of post-transplantation recurrence involving pathogenic variants in NPHS2 (8 patients, biallelic), one in WT1 (monoallelic) and one in NUP93 (biallelic). However, the mechanism for recurrence in these cases remains unclear. Other instances of recurrence in genetic disease were difficult to interpret due to differing clinical criteria, inclusion of patients without true pathogenic variants or the influence of other factors on renal outcome. Conclusions: Overall, post-transplantation recurrence remains very rare in patients with genetic SRNS. It appears to occur later after transplantation than in other patients and usually responds well to plasmapheresis with a good renal outcome.Keywords
Funding Information
- Kidney Research UK
- Elizabeth Blackwell Institute
- Wellcome Trust
This publication has 45 references indexed in Scilit:
- Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantationNephrology Dialysis Transplantation, 2009
- Novel Mutations in NPHP4 in a Consanguineous Family With Histological Findings of Focal Segmental GlomerulosclerosisAmerican Journal of Kidney Diseases, 2007
- Recurrent Nephrotic Syndrome in Homozygous Truncating NPHS2 Mutation Is Not Due to Anti-Podocin AntibodiesAmerican Journal of Transplantation, 2006
- Posttransplant Recurrence of Proteinuria in a Case of Focal Segmental Glomerulosclerosis Associated with WT1 MutationAmerican Journal of Transplantation, 2006
- Recurrence of Focal-Segmental Glomerulosclerosis in Children after Renal Transplantation: Clinical and Genetic AspectsTransplantation, 2005
- Unusual post-transplantation recurrence of focal segmental glomerulosclerosis which resolved with cyclosporine but not with sirolimusTransplant International, 2005
- NPHS2 mutation associated with recurrence of proteinuria after transplantationPediatric Nephrology, 2004
- Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic SyndromeJournal of the American Society of Nephrology, 2004
- Early Glomerular Filtration Defect and Severe Renal Disease in Podocin-Deficient MiceMolecular and Cellular Biology, 2004
- Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in childrenAmerican Journal of Kidney Diseases, 1999